• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 8300AB23A
Device Problems Calcified (1077); Insufficient Information (3190)
Patient Problems Anemia (1706); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
Event Date 03/06/2024
Event Type  Injury  
Manufacturer Narrative
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was learned via the patient registry that a patient with a 23mm 8300ab intuity valve underwent a redo aortic valve replacement procedure after an implant duration of six (6) years, six (6) months due to unknown reasons.The explanted valve was replaced with a 23mm 11500a inspiris valve.
 
Manufacturer Narrative
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Calcific degeneration is a common cause of bioprosthetic heart valve failures.Many factors contribute to the onset and propagation of calcification.These include patient factors (age, disease state, pharmacological intervention, etc.), mechanical stress related to the valve's hemodynamic performance, and glutaraldehyde fixation of tissue.Of these, the fixation process is a relatively minor contributor to calcification for edwards' tissue valves due to anti-calcification treatments during manufacturing.Though numerous studies have been conducted on preventive calcification strategies in bioprosthetic heart valves, the causes of calcification are not fully understood and there are still no mechanisms or medical therapies which fully prevent bioprostheses from calcifying.Calcification is most commonly related to patient factors and is not usually an indication of a device malfunction related to a manufacturing deficiency.The instructions for use (ifu) have been reviewed and no inadequacies have been identified with regard to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.A capa/scar/pra is not required, as there are no confirmed product or labeling non-conformances and no other triggers are met.The most likely cause is patient factors, including hyperlipidemia and chronic kidney disease.
 
Event Description
It was learned via the patient registry that a patient with a 23mm 8300ab intuity valve underwent a redo aortic valve replacement procedure after an implant duration of six (6) years, six (6) months due to severe aortic valve insufficiency secondary to calcification.The patient presented with acute-on-chronic congestive heart failure and anemia.The explanted valve was replaced with a 23mm 11500a inspiris valve.The valve seated well.The aortic valve was functioning well and hemodynamics were acceptable but marginal.Iabp was inserted to support post cardiotomy myocardial dysfunciton.The patient was transferred to the cvicu in critical but stable condition.Post-operative course was further complicated by atrial fibrillation/flutter treated with amiodarone and then prolonged qtc on oral beta-blockers.The patient was discharged home on pod #10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INTUITY ELITE VALVE SYSTEM
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
irvine, CA 92614
9492506615
MDR Report Key19054917
MDR Text Key339549527
Report Number2015691-2024-02636
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194494
UDI-Public(01)00690103194494(17)181023
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date10/23/2018
Device Model Number8300AB23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/11/2024
Initial Date FDA Received04/05/2024
Supplement Dates Manufacturer Received04/17/2024
Supplement Dates FDA Received05/09/2024
Date Device Manufactured10/23/2016
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age72 YR
Patient SexMale
-
-